<DOC>
	<DOC>NCT01928901</DOC>
	<brief_summary>Proof of concept: Superiority of Bronchipret or Sinupret to placebo in respect to mucociliary clearance</brief_summary>
	<brief_title>Trial With Bronchipret and Sinupret to Evaluate Acceleration of Mucociliary Clearance (MCC)</brief_title>
	<detailed_description />
	<mesh_term>Thymol</mesh_term>
	<criteria>1. Volunteers who have given their signed declaration of consent and have signed the data protection declaration 2. Male or female volunteers 25 40 years 3. Current smokers (520 cigarettes per day since 5 years at least) 4. Ability to taste sweetness of saccharin 5. Perception of sweetness within 30 minutes after placement of saccharin behind nasal valve 1. Ciliary dyskinesia 2. Cystic fibrosis 3. COPD/emphysema 4. Asthma 5. Chronic rhinosinusitis 6. Acute respiratory tract infection within the last 6 weeks prior to enrolment 7. Septal or sinus surgery 8. Symptomatic allergic rhinitis 9. Known allergic rhinitis 10. Treatment with notpermitted previous or concomitant therapy 11. History of snuff consumption for longer than 1 month or intranasal consumption of recreational drugs such as cocaine or heroin for longer than 1 month 12. Any disease or condition that might affect the safety of the subject during the trial, according to the investigator's judgement</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>